Bhatia M et al. |
An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients. |
2010 |
Biol. Blood Marrow Transplant. |
pmid:19835971
|
Devine SM et al. |
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. |
1997 |
Biol. Blood Marrow Transplant. |
pmid:9209738
|
Ohata K et al. |
Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen. |
2011 |
Biol. Blood Marrow Transplant. |
pmid:20736080
|
Kolb M et al. |
Risk Factors for Subtherapeutic Tacrolimus Levels after Conversion from Continuous Intravenous Infusion to Oral in Children after Allogeneic Hematopoietic Cell Transplantation. |
2016 |
Biol. Blood Marrow Transplant. |
pmid:26880117
|
Koreth J et al. |
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial. |
2015 |
Biol. Blood Marrow Transplant. |
pmid:26055298
|
Klein OR et al. |
Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders. |
2016 |
Biol. Blood Marrow Transplant. |
pmid:26860634
|
Kennedy-Nasser AA et al. |
Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. |
2006 |
Biol. Blood Marrow Transplant. |
pmid:17162209
|
Kusumi E et al. |
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases. |
2006 |
Biol. Blood Marrow Transplant. |
pmid:17162212
|
Chen YB et al. |
Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma. |
2015 |
Biol. Blood Marrow Transplant. |
pmid:26009261
|
Kebriaei P et al. |
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. |
2009 |
Biol. Blood Marrow Transplant. |
pmid:19539211
|
Ho VT et al. |
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. |
2009 |
Biol. Blood Marrow Transplant. |
pmid:19539216
|
Osunkwo I et al. |
A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. |
2004 |
Biol. Blood Marrow Transplant. |
pmid:15077223
|
Yahng SA et al. |
A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia. |
2015 |
Biol. Blood Marrow Transplant. |
pmid:25300871
|
Horowitz MM et al. |
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. |
1999 |
Biol. Blood Marrow Transplant. |
pmid:10392964
|
Cutler C et al. |
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. |
2005 |
Biol. Blood Marrow Transplant. |
pmid:15846292
|
Tomblyn MR et al. |
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. |
2011 |
Biol. Blood Marrow Transplant. |
pmid:21073974
|
Park SS et al. |
Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. |
2017 |
Biol. Blood Marrow Transplant. |
pmid:28554856
|
Openshaw H |
Peripheral neuropathy after bone marrow transplantation. |
1997 |
Biol. Blood Marrow Transplant. |
pmid:9360782
|
Baird K et al. |
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. |
2015 |
Biol. Blood Marrow Transplant. |
pmid:25771402
|
Yagasaki H et al. |
Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis. |
2009 |
Biol. Blood Marrow Transplant. |
pmid:19896085
|
Carnevale-Schianca F et al. |
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease. |
2000 |
Biol. Blood Marrow Transplant. |
pmid:11128811
|
Vasu S et al. |
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease. |
2016 |
Biol. Blood Marrow Transplant. |
pmid:26743340
|
Satwani P et al. |
A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen. |
2012 |
Biol. Blood Marrow Transplant. |
pmid:22079471
|
Treister N et al. |
An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease. |
2016 |
Biol. Blood Marrow Transplant. |
pmid:27590106
|
Sabry W et al. |
Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality. |
2009 |
Biol. Blood Marrow Transplant. |
pmid:19589481
|
Burroughs LM et al. |
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. |
2014 |
Biol. Blood Marrow Transplant. |
pmid:25196857
|
Kanate AS et al. |
Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. |
2017 |
Biol. Blood Marrow Transplant. |
pmid:28412518
|
Pavletic S and Vogelsand GB |
Treatment of high-risk chronic GVHD. |
2008 |
Biol. Blood Marrow Transplant. |
pmid:19041069
|
Piñana JL et al. |
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis. |
2017 |
Biol. Blood Marrow Transplant. |
pmid:28396159
|
Rosenbeck LL et al. |
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation. |
2011 |
Biol. Blood Marrow Transplant. |
pmid:20932925
|
Carmona A et al. |
Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide. |
2013 |
Biol. Blood Marrow Transplant. |
pmid:23845694
|
Oran B et al. |
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. |
2007 |
Biol. Blood Marrow Transplant. |
pmid:17382253
|
Cutler C et al. |
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. |
2004 |
Biol. Blood Marrow Transplant. |
pmid:15111932
|
Cutler C et al. |
Generic immunosuppressants in hematopoietic cell transplantation. |
2011 |
Biol. Blood Marrow Transplant. |
pmid:21087678
|
Ram R et al. |
Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation. |
2012 |
Biol. Blood Marrow Transplant. |
pmid:21875504
|
Leather H et al. |
Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients. |
2006 |
Biol. Blood Marrow Transplant. |
pmid:16503502
|
Solomon SR et al. |
Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors. |
2015 |
Biol. Blood Marrow Transplant. |
pmid:25797174
|
Grossman J et al. |
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. |
2014 |
Biol. Blood Marrow Transplant. |
pmid:25111582
|
Luznik L et al. |
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. |
2008 |
Biol. Blood Marrow Transplant. |
pmid:18489989
|
Snyder DS et al. |
Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis. |
2010 |
Biol. Blood Marrow Transplant. |
pmid:19786111
|
Hamilton BK and Kalaycio M |
Maximizing the benefits of mycophenolate mofetil as graft-versus-host disease prophylaxis. |
2014 |
Biol. Blood Marrow Transplant. |
pmid:25065905
|
Narimatsu H et al. |
Early central nervous complications after umbilical cord blood transplantation for adults. |
2009 |
Biol. Blood Marrow Transplant. |
pmid:19135947
|
Platzbecker U et al. |
Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial. |
2009 |
Biol. Blood Marrow Transplant. |
pmid:19135948
|
Alyea EP et al. |
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. |
2008 |
Biol. Blood Marrow Transplant. |
pmid:18640576
|
Wolff D et al. |
Sirolimus in combination with tacrolimus in allogeneic stem cell transplantation--timing and conditioning regimen may be crucial. |
2008 |
Biol. Blood Marrow Transplant. |
pmid:18640579
|
Shayani S et al. |
Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis. |
2013 |
Biol. Blood Marrow Transplant. |
pmid:23078784
|
Mori T et al. |
Effect of early posttransplantation tacrolimus concentration on the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors. |
2012 |
Biol. Blood Marrow Transplant. |
pmid:21708109
|
Nieto Y et al. |
Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation. |
2006 |
Biol. Blood Marrow Transplant. |
pmid:16443519
|
Uberti JP et al. |
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease. |
2005 |
Biol. Blood Marrow Transplant. |
pmid:16125638
|
Perkins J et al. |
A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis. |
2010 |
Biol. Blood Marrow Transplant. |
pmid:20102746
|
Kumar AJ et al. |
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation. |
2013 |
Biol. Blood Marrow Transplant. |
pmid:23635453
|
Miyakoshi S et al. |
Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases. |
2007 |
Biol. Blood Marrow Transplant. |
pmid:17580255
|
Goyal RK et al. |
Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation. |
2013 |
Biol. Blood Marrow Transplant. |
pmid:23266742
|
Al-Kadhimi Z et al. |
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation. |
2012 |
Biol. Blood Marrow Transplant. |
pmid:22710143
|
Przepiorka D et al. |
Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation. |
1999 |
Biol. Blood Marrow Transplant. |
pmid:10371361
|
Przepiorka D et al. |
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1. |
2000 |
Biol. Blood Marrow Transplant. |
pmid:10816027
|
Cuellar-Rodriguez J et al. |
Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. |
2015 |
Biol. Blood Marrow Transplant. |
pmid:25636378
|
Wingard JR et al. |
Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation. |
1998 |
Biol. Blood Marrow Transplant. |
pmid:9923414
|
Ogawa H et al. |
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. |
2006 |
Biol. Blood Marrow Transplant. |
pmid:17084371
|
Khaled SK et al. |
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. |
2016 |
Biol. Blood Marrow Transplant. |
pmid:26325438
|
Satwani P et al. |
Risk factors associated with kidney injury and the impact of kidney injury on overall survival in pediatric recipients following allogeneic stem cell transplant. |
2011 |
Biol. Blood Marrow Transplant. |
pmid:21338706
|
Carnevale-Schianca F et al. |
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors. |
2017 |
Biol. Blood Marrow Transplant. |
pmid:28039079
|
Inamoto Y et al. |
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells. |
2011 |
Biol. Blood Marrow Transplant. |
pmid:21421070
|
Offer K et al. |
Efficacy of tacrolimus/mycophenolate mofetil as acute graft-versus-host disease prophylaxis and the impact of subtherapeutic tacrolimus levels in children after matched sibling donor allogeneic hematopoietic cell transplantation. |
2015 |
Biol. Blood Marrow Transplant. |
pmid:25536217
|
Aldoss I et al. |
Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. |
2016 |
Biol. Blood Marrow Transplant. |
pmid:27044907
|
Furlong T et al. |
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors. |
2008 |
Biol. Blood Marrow Transplant. |
pmid:18410895
|
Kim HJ et al. |
Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. |
2009 |
Biol. Blood Marrow Transplant. |
pmid:19450755
|
Small TN et al. |
Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies. |
2007 |
Biol. Blood Marrow Transplant. |
pmid:17241929
|
Carnevale-Schianca F et al. |
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study. |
2009 |
Biol. Blood Marrow Transplant. |
pmid:19450760
|
Santarone S et al. |
Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemia. |
2011 |
Biol. Blood Marrow Transplant. |
pmid:21385623
|
Al-Kadhimi Z et al. |
High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients. |
2014 |
Biol. Blood Marrow Transplant. |
pmid:24709007
|
Gladstone DE et al. |
Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies. |
2013 |
Biol. Blood Marrow Transplant. |
pmid:23353119
|
Socié G |
Graft-versus-host disease prophylaxis: does drug dosage matter? |
2012 |
Biol. Blood Marrow Transplant. |
pmid:22200648
|
Moiseev IS et al. |
Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil. |
2016 |
Biol. Blood Marrow Transplant. |
pmid:26970381
|
Hamadani M et al. |
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies. |
2009 |
Biol. Blood Marrow Transplant. |
pmid:19822302
|
Inamoto Y et al. |
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia. |
2015 |
Biol. Blood Marrow Transplant. |
pmid:26033280
|
Cadou A et al. |
The Kin1 kinase and the calcineurin phosphatase cooperate to link actin ring assembly and septum synthesis in fission yeast. |
2013 |
Biol. Cell |
pmid:23294323
|
Homma M et al. |
False positive blood tacrolimus concentration in microparticle enzyme immunoassay. |
2002 |
Biol. Pharm. Bull. |
pmid:12186423
|
Hazama Y et al. |
Effect of Physiological Changes in the Skin on Systemic Absorption of Tacrolimus Following Topical Application in Rats. |
2016 |
Biol. Pharm. Bull. |
pmid:26934927
|
Takeuchi H et al. |
Evidence of different pharmacokinetics including relationship among AUC, peak, and trough levels between cyclosporine and tacrolimus in renal transplant recipients using new pharmacokinetic parameter--why cyclosporine is monitored by C(2) level and tacrolimus by trough level--. |
2008 |
Biol. Pharm. Bull. |
pmid:18175948
|
Zhu Y et al. |
Participation of proteinase-activated receptor-2 in passive cutaneous anaphylaxis-induced scratching behavior and the inhibitory effect of tacrolimus. |
2009 |
Biol. Pharm. Bull. |
pmid:19571380
|
Kawazoe H et al. |
Change of the blood concentration of tacrolimus after the switch from fluconazole to voriconazole in patients receiving allogeneic hematopoietic stem cell transplantation. |
2006 |
Biol. Pharm. Bull. |
pmid:17142996
|
Uesugi M et al. |
Influence of cytochrome P450 (CYP) 3A4*1G polymorphism on the pharmacokinetics of tacrolimus, probability of acute cellular rejection, and mRNA expression level of CYP3A5 rather than CYP3A4 in living-donor liver transplant patients. |
2013 |
Biol. Pharm. Bull. |
pmid:24189425
|
Takeuchi H et al. |
Steroid withdrawal based on lymphocyte sensitivity to endogenous steroid in renal transplant recipients. |
2011 |
Biol. Pharm. Bull. |
pmid:21963498
|
Okada Y et al. |
Tacrolimus ameliorates dextran sulfate sodium-induced colitis in mice: implication of interferon-γ and interleukin-1β suppression. |
2011 |
Biol. Pharm. Bull. |
pmid:22130237
|
Sakamoto Y et al. |
Correlation between neurotoxic events and intracerebral concentration of tacrolimus in rats. |
2000 |
Biol. Pharm. Bull. |
pmid:10963314
|
Sasa H et al. |
Hepatic extraction of tacrolimus in rats with experimental liver diseases. |
1998 |
Biol. Pharm. Bull. |
pmid:9657047
|
Tomita T et al. |
Use of sample hematocrit value to correct blood tacrolimus concentration derived by microparticle enzyme immunoassay. |
2008 |
Biol. Pharm. Bull. |
pmid:18520063
|
Fukuoka N et al. |
Erythroid recovery affects tacrolimus levels after engraftment during stem cell transplantation. |
2012 |
Biol. Pharm. Bull. |
pmid:23037155
|
Naito T et al. |
Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation. |
2006 |
Biol. Pharm. Bull. |
pmid:16462031
|
Naito T et al. |
Influence of metal cations on plasma trough concentration of mycophenolic Acid and its glucuronide in tacrolimus-treated and cyclosporine-treated kidney transplant recipients. |
2008 |
Biol. Pharm. Bull. |
pmid:18520072
|
Sakai M et al. |
Increased bioavailability of tacrolimus after rectal administration in rats. |
2004 |
Biol. Pharm. Bull. |
pmid:15340245
|
Minematsu T et al. |
Pharmacokinetic/pharmacodynamic analysis of tacrolimus-induced QT prolongation in guinea pigs. |
1999 |
Biol. Pharm. Bull. |
pmid:10746167
|
Miura M et al. |
Inter-laboratory Variability of Current Immunoassay Methods for Tacrolimus among Japanese Hospitals. |
2016 |
Biol. Pharm. Bull. |
pmid:27263473
|
Yamaguchi K et al. |
Limited sampling strategy for the estimation of mycophenolic acid area under the concentration-time curve treated in Japanese living-related renal transplant recipients with concomitant extended-release tacrolimus. |
2013 |
Biol. Pharm. Bull. |
pmid:23558676
|
Nakano T et al. |
Effects of topical application of tacrolimus on acute itch-associated responses in mice. |
2008 |
Biol. Pharm. Bull. |
pmid:18379077
|
Kinugasa F et al. |
Effect of a new immunosuppressant histon deacetylase (HDAC) inhibitor FR276457 in a rat cardiac transplant model. |
2008 |
Biol. Pharm. Bull. |
pmid:18758066
|
Noto T et al. |
Tacrolimus (FK506) limits accumulation of granulocytes and platelets and protects against brain damage after transient focal cerebral ischemia in rat. |
2007 |
Biol. Pharm. Bull. |
pmid:17268072
|
Mahakunakorn P et al. |
Cytoprotective and cytotoxic effects of curcumin: dual action on H2O2-induced oxidative cell damage in NG108-15 cells. |
2003 |
Biol. Pharm. Bull. |
pmid:12736521
|
Shimoeda S et al. |
Analysis of the blood level of micafungin involving patients with hematological diseases: new findings regarding combination therapy with tacrolimus. |
2005 |
Biol. Pharm. Bull. |
pmid:15744072
|